Skin Cell Labs Limited 10636289 false 2023-03-01 2024-02-29 2024-02-29 The principal activity of the company is skin care Digita Accounts Production Advanced 6.30.9574.0 true 10636289 2023-03-01 2024-02-29 10636289 2024-02-29 10636289 bus:OrdinaryShareClass1 2024-02-29 10636289 core:CurrentFinancialInstruments 2024-02-29 10636289 core:CurrentFinancialInstruments core:WithinOneYear 2024-02-29 10636289 core:Non-currentFinancialInstruments core:AfterOneYear 2024-02-29 10636289 bus:SmallEntities 2023-03-01 2024-02-29 10636289 bus:AuditExemptWithAccountantsReport 2023-03-01 2024-02-29 10636289 bus:FullAccounts 2023-03-01 2024-02-29 10636289 bus:SmallCompaniesRegimeForAccounts 2023-03-01 2024-02-29 10636289 bus:RegisteredOffice 2023-03-01 2024-02-29 10636289 bus:Director1 2023-03-01 2024-02-29 10636289 bus:Director2 2023-03-01 2024-02-29 10636289 bus:OrdinaryShareClass1 2023-03-01 2024-02-29 10636289 bus:PrivateLimitedCompanyLtd 2023-03-01 2024-02-29 10636289 countries:UnitedKingdom 2023-03-01 2024-02-29 10636289 2022-03-01 2023-02-28 10636289 2023-02-28 10636289 bus:OrdinaryShareClass1 2023-02-28 10636289 core:CurrentFinancialInstruments 2023-02-28 10636289 core:CurrentFinancialInstruments core:WithinOneYear 2023-02-28 10636289 core:Non-currentFinancialInstruments core:AfterOneYear 2023-02-28 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 10636289

Skin Cell Labs Limited

Annual Report and Unaudited Financial Statements

for the Year Ended 29 February 2024

 

Skin Cell Labs Limited

Contents

Balance Sheet

1

Notes to the Unaudited Financial Statements

2 to 3

 

Skin Cell Labs Limited

(Registration number: 10636289)
Balance Sheet as at 29 February 2024

Note

2024
£

2023
£

Current assets

 

Debtors

4

259

359

Cash at bank and in hand

 

444

12,626

 

703

12,985

Creditors: Amounts falling due within one year

5

(3,948)

(3,342)

Total assets less current liabilities

 

(3,245)

9,643

Creditors: Amounts falling due after more than one year

5

(199,379)

(197,393)

Net liabilities

 

(202,624)

(187,750)

Capital and reserves

 

Called up share capital

6

10

10

Share premium reserve

50,494

50,494

Retained earnings

(253,128)

(238,254)

Shareholders' deficit

 

(202,624)

(187,750)

For the financial year ending 29 February 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

Approved and authorised by the Board on 25 November 2024 and signed on its behalf by:
 

Mr P M Ineson
Director

Mr K M Wronski
Director

 
     
 

Skin Cell Labs Limited

Notes to the Unaudited Financial Statements for the Year Ended 29 February 2024

1

General information

The company is a private company limited by share capital, incorporated in United Kingdom.

The address of its registered office is:
Parkhill Studio
Walton Road
Wetherby
West Yorkshire
LS22 5DZ
England

These financial statements were authorised for issue by the Board on 25 November 2024.

2

Accounting policies

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 2 (2023 - 2).

4

Debtors

Current

2024
£

2023
£

Other debtors

259

359

 

259

359

 

Skin Cell Labs Limited

Notes to the Unaudited Financial Statements for the Year Ended 29 February 2024

5

Creditors

Creditors: amounts falling due within one year

Note

2024
£

2023
£

Due within one year

 

Loans and borrowings

3,354

3,042

Trade creditors

 

49

-

Taxation and social security

 

145

-

Accruals and deferred income

 

400

300

 

3,948

3,342

Creditors: amounts falling due after more than one year

Note

2024
£

2023
£

Due after one year

 

Loans and borrowings

199,379

197,393

6

Share capital

Allotted, called up and fully paid shares

2024

2023

No.

£

No.

£

Ordinary shares of £0.01 each

1,000

10

1,000

10